tiprankstipranks
Trending News
More News >
Appili Therapeutics Inc Class A (TSE:APLI)
TSX:APLI
Canadian Market

Appili Therapeutics Inc Class A (APLI) Ratios

Compare
26 Followers

Appili Therapeutics Inc Class A Ratios

TSE:APLI's free cash flow for Q2 2026 was C$0.97. For the 2026 fiscal year, TSE:APLI's free cash flow was decreased by C$ and operating cash flow was C$-10.35. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
0.05 0.13 0.13 0.13 1.05
Quick Ratio
0.05 0.13 0.13 0.13 1.05
Cash Ratio
0.02 <0.01 <0.01 <0.01 0.83
Solvency Ratio
-0.15 -0.30 -0.30 -0.30 -0.88
Operating Cash Flow Ratio
-0.01 -0.21 -0.21 -0.21 -3.39
Short-Term Operating Cash Flow Coverage
-0.01 -0.34 -0.34 -0.34 -89.26
Net Current Asset Value
C$ -15.62MC$ -10.95MC$ -10.95MC$ -7.41MC$ -3.31M
Leverage Ratios
Debt-to-Assets Ratio
16.20 5.49 5.49 5.49 2.45
Debt-to-Equity Ratio
-0.78 -0.75 -0.75 -0.75 -1.04
Debt-to-Capital Ratio
-3.61 -2.99 -2.99 -2.99 28.56
Long-Term Debt-to-Capital Ratio
-0.04 -0.09 -0.09 -0.09 48.65
Financial Leverage Ratio
-0.05 -0.14 -0.14 -0.14 -0.42
Debt Service Coverage Ratio
-0.07 -0.24 -0.24 -0.24 -6.81
Interest Coverage Ratio
-0.76 -1.33 -1.33 -1.33 -7.22
Debt to Market Cap
4.03 1.93 1.93 1.93 1.68
Interest Debt Per Share
0.12 0.08 0.08 0.08 0.08
Net Debt to EBITDA
-13.48 -3.91 -3.91 -0.64 0.07
Profitability Margins
Gross Profit Margin
94.52%100.00%100.00%100.00%98.12%
EBIT Margin
-448.34%-251.43%-251.43%-251.43%-2427.02%
EBITDA Margin
-441.25%-253.37%-253.37%-253.37%-2451.79%
Operating Profit Margin
-847.75%-261.39%-261.39%-261.39%-2368.29%
Pretax Profit Margin
-1227.63%-448.55%-448.55%-448.55%-2755.01%
Net Profit Margin
-1269.45%-456.96%-456.96%-456.96%-2765.90%
Continuous Operations Profit Margin
-1269.45%-456.96%-456.96%-456.96%-2765.90%
Net Income Per EBT
103.41%101.87%101.87%101.87%100.40%
EBT Per EBIT
144.81%171.60%171.60%171.60%116.33%
Return on Assets (ROA)
-335.99%-253.68%-253.68%-295.08%-303.30%
Return on Equity (ROE)
17.71%34.61%34.61%124.96%768.02%
Return on Capital Employed (ROCE)
11.29%21.52%21.52%-5098.06%-1530.37%
Return on Invested Capital (ROIC)
50.03%78.94%78.94%-2949.06%-1444.76%
Return on Tangible Assets
-335.99%-253.68%-253.68%-295.08%-303.30%
Earnings Yield
-83.62%-89.08%-89.08%-203.18%-313.68%
Efficiency Ratios
Receivables Turnover
0.99 0.71 0.71 0.71 0.79
Payables Turnover
<0.01 0.00 0.00 0.00 <0.01
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
16.39 27.45 27.45 27.45 22.87
Asset Turnover
0.26 0.56 0.56 0.56 0.11
Working Capital Turnover Ratio
-0.01 -0.17 -0.17 -0.17 0.39
Cash Conversion Cycle
-106.03K 517.60 517.60 -144.04K 365.10
Days of Sales Outstanding
368.48 517.60 517.60 459.60 365.10
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
106.40K 0.00 0.00 144.50K 0.00
Operating Cycle
368.48 517.60 517.60 459.60 365.10
Cash Flow Ratios
Operating Cash Flow Per Share
>-0.01 -0.02 -0.02 -0.02 -0.09
Free Cash Flow Per Share
>-0.01 -0.02 -0.02 -0.02 -0.09
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.01 1.01 1.01 1.00
Dividend Paid and CapEx Coverage Ratio
-247.68 -82.93 -82.93 -82.93 -3.18K
Capital Expenditure Coverage Ratio
-247.68 -82.93 -82.93 -82.93 -3.18K
Operating Cash Flow Coverage Ratio
-0.01 -0.30 -0.30 -0.30 -1.32
Operating Cash Flow to Sales Ratio
-0.87 -2.98 -2.98 -2.98 -30.22
Free Cash Flow Yield
-5.76%-58.76%-58.76%-222.04%-238.28%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-1.20 -1.12 -1.12 -1.12 -0.49
Price-to-Sales (P/S) Ratio
15.18 5.13 5.13 5.13 13.61
Price-to-Book (P/B) Ratio
-0.19 -0.39 -0.39 -0.39 -0.62
Price-to-Free Cash Flow (P/FCF) Ratio
-17.37 -1.70 -1.70 -1.70 -0.45
Price-to-Operating Cash Flow Ratio
-17.44 -1.72 -1.72 -1.72 -0.45
Price-to-Earnings Growth (PEG) Ratio
0.11 0.02 0.02 0.02 <0.01
Price-to-Fair Value
-0.19 -0.39 -0.39 -0.39 -0.62
Enterprise Value Multiple
-16.92 -5.88 -5.88 -5.88 -1.19
Enterprise Value
14.91M 12.33M 12.33M 9.75M 6.32M
EV to EBITDA
-16.92 -5.97 -5.97 -1.20 -0.27
EV to Sales
74.64 14.91 14.91 29.17 4.55
EV to Free Cash Flow
-85.38 -4.95 -4.95 -0.97 -0.33
EV to Operating Cash Flow
-85.73 -5.01 -5.01 -0.97 -0.33
Tangible Book Value Per Share
-0.13 -0.09 -0.09 -0.09 -0.07
Shareholders’ Equity Per Share
-0.13 -0.09 -0.09 -0.09 -0.07
Tax and Other Ratios
Effective Tax Rate
-0.03 -0.02 -0.02 -0.02 >-0.01
Revenue Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Net Income Per Share
-0.02 -0.03 -0.03 -0.03 -0.08
Tax Burden
1.03 1.02 1.02 1.00 1.00
Interest Burden
2.74 1.78 1.78 1.14 1.07
Research & Development to Revenue
25.28 6.80 6.80 11.40 15.43
SG&A to Revenue
13.23 3.68 3.68 13.28 3.32
Stock-Based Compensation to Revenue
0.27 0.23 0.23 2.62 1.47
Income Quality
0.07 0.65 0.65 1.09 0.76
Currency in CAD